Topas Therapeutics Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$48.6M
- Investors
-
8
Topas Therapeutics General Information
Description
Developer of nanoparticle-based therapeutics designed to treat autoimmune diseases, allergies, and anti-drug antibodies. The company's therapeutics induce antigen-specific immune tolerance by harnessing the liver's natural immunology capabilities targeting liver sinusoidal endothelial cells (LSECs), enabling patients to have tolerance against blood-borne antigens important for maintaining immune tolerance.
Contact Information
Website
www.topas-therapeutics.comCorporate Office
- Falkenried 88
- Haus A
- 20251 Hamburg
- Germany
Corporate Office
- Falkenried 88
- Haus A
- 20251 Hamburg
- Germany
Topas Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series B) | 02-Jul-2021 | $48.6M | Completed | Clinical Trials - Phase 2 | ||
| 1. Later Stage VC (Series A) | 18-Jan-2018 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Topas Therapeutics Comparisons
Industry
Financing
Details
Topas Therapeutics Competitors (22)
One of Topas Therapeutics’s 22 competitors is Anokion, a Venture Capital-Backed company based in Ecublens, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Anokion | Venture Capital-Backed | Ecublens, Switzerland | ||||
| Regenacy Pharmaceuticals | Venture Capital-Backed | Waltham, MA | ||||
| NexImmune | Formerly VC-backed | Gaithersburg, MD | ||||
| TolerogenixX | Venture Capital-Backed | Heidelberg, Germany | ||||
| Genocea Biosciences | Formerly VC-backed | Cambridge, MA |
Topas Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Topas Therapeutics Patents
Topas Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4137121-A1 | Pharmaceutical compositions comprising nanoparticles for the targeted delivery of antigens | Inactive | 17-Aug-2021 | ||
| CA-3228074-A1 | Pharmaceutical composition comprising nanoparticles for the targeted delivery of antigens | Pending | 17-Aug-2021 | ||
| EP-4387590-A2 | Pharmaceutical composition comprising nanoparticles for the targeted delivery of antigens | Pending | 17-Aug-2021 | ||
| AU-2022330328-A1 | Pharmaceutical composition comprising nanoparticles for the targeted delivery of antigens | Pending | 17-Aug-2021 | ||
| US-20240424089-A1 | Pharmaceutical composition comprising nanoparticles for the targeted delivery of antigens | Pending | 17-Aug-2021 | A61K39/385 |
Topas Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Topas Therapeutics Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioMedPartners | Venture Capital | Minority | ||
| Vesalius Biocapital Partners | Venture Capital | Minority | ||
| Boehringer Ingelheim Venture Fund | Corporate Venture Capital | Minority | ||
| Eli Lilly | Corporation | Minority | ||
| EMBL Ventures | Venture Capital | Minority |
Topas Therapeutics FAQs
-
When was Topas Therapeutics founded?
Topas Therapeutics was founded in 2013.
-
Where is Topas Therapeutics headquartered?
Topas Therapeutics is headquartered in Hamburg, Germany.
-
What is the size of Topas Therapeutics?
Topas Therapeutics has 19 total employees.
-
What industry is Topas Therapeutics in?
Topas Therapeutics’s primary industry is Drug Discovery.
-
Is Topas Therapeutics a private or public company?
Topas Therapeutics is a Private company.
-
What is the current valuation of Topas Therapeutics?
The current valuation of Topas Therapeutics is .
-
What is Topas Therapeutics’s current revenue?
The current revenue for Topas Therapeutics is .
-
How much funding has Topas Therapeutics raised over time?
Topas Therapeutics has raised $70.3M.
-
Who are Topas Therapeutics’s investors?
BioMedPartners, Vesalius Biocapital Partners, Boehringer Ingelheim Venture Fund, Eli Lilly, and EMBL Ventures are 5 of 8 investors who have invested in Topas Therapeutics.
-
Who are Topas Therapeutics’s competitors?
Anokion, Regenacy Pharmaceuticals, NexImmune, TolerogenixX, and Genocea Biosciences are some of the 22 competitors of Topas Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
